H10.51 Ligneous conjunctivitis

Name of the Condition

• Ligneous conjunctivitis

Summary

Ligneous conjunctivitis is a rare, chronic inflammatory disorder of the conjunctiva characterized by the formation of thick, fibrinous pseudomembranes. It often presents with persistent redness, irritation, and discharge, and may involve one or both eyes. The condition can result from underlying systemic or ocular factors, and symptoms typically include eyelid swelling, itching, and a gritty sensation.

Causes

Ligneous conjunctivitis is commonly associated with deficiencies in plasminogen or other fibrinolytic pathway abnormalities. Infections, such as bacterial or fungal, may also contribute. Allergic reactions to environmental triggers or irritants may play a role. In some cases, underlying systemic conditions like plasminogen deficiency or autoimmune disorders can drive inflammation.

Risk Factors

• Plasminogen deficiency or other fibrinolytic pathway abnormalities.
• Chronic ocular infections or inflammation.
• Exposure to allergens or irritants (e.g., chemicals, smoke).
• Pre-existing systemic conditions (e.g., autoimmune disorders).
• Compromised immune system or chronic eye irritation.

Symptoms

• Redness and swelling of the conjunctiva.
• Itching, burning, or gritty sensation in the eye.
• Thick, fibrinous pseudomembrane formation on the conjunctiva.
• Discharge (watery, mucous, or purulent) from the eye.
• Crusting of eyelashes, particularly upon waking.
• Sensitivity to light (photophobia).

Diagnosis

Diagnosis is based on clinical examination of the conjunctiva, which reveals characteristic fibrinous pseudomembranes. Laboratory tests, including plasminogen levels and coagulation studies, may be performed to identify underlying causes. Biopsy of the conjunctival tissue may be considered to rule out other conditions. Imaging or additional tests may be used to assess systemic involvement.

Treatment Options

Treatment focuses on managing inflammation and addressing underlying causes. Topical or systemic corticosteroids may be used to reduce inflammation. Antifibrinolytic agents or plasminogen replacement therapy may be considered in cases of plasminogen deficiency. Surgical removal of pseudomembranes may be necessary in severe cases. Lubricating eye drops or ointments can help relieve symptoms.

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and response to treatment. Chronic or recurrent cases may require long-term management. Regular follow-up with an ophthalmologist is recommended to monitor for recurrence or complications. Early intervention can help prevent permanent damage to the conjunctiva or cornea.

Complications

• Corneal scarring or opacity.
• Vision impairment due to chronic inflammation.
• Recurrent pseudomembrane formation.
• Secondary infections (bacterial or fungal).
• Chronic dry eye or discomfort.

Lifestyle & Prevention

• Maintain good ocular hygiene to reduce irritation.
• Avoid exposure to known allergens or irritants.
• Use lubricating eye drops to keep the eyes moist.
• Follow prescribed treatment regimens consistently.
• Protect the eyes from smoke, dust, or other environmental triggers.

When to Seek Professional Help

Seek medical attention if symptoms worsen, persist despite treatment, or if new symptoms like severe pain, vision changes, or increased discharge occur. Prompt evaluation is important to prevent complications and adjust treatment as needed.

Tips for Medical Coders

When coding for ligneous conjunctivitis, use ICD-10-CM code H10.51. Ensure documentation supports the diagnosis, including clinical findings (e.g., pseudomembranes) and any underlying causes (e.g., plasminogen deficiency). Verify that the code aligns with the specific eye involvement and any associated systemic conditions. Accurate coding requires clear documentation of the condition's characteristics and treatment.